Gülay ÖZGEHAN, Şahin KAHRAMANCA, İsmail Oskay KAYA, Köksal BİLGEN, Hasan BOSTANCI, Hakan GÜZEL, Tevfik KÜÇÜKPINAR, Hülagü KARGICI

Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer

In the preoperative period, simple methods to identify the tumor stage of colorectal cancer patients are needed. In recent years, the neutrophil-lymphocyte ratio (NLR) has been used as a predictive parameter for systemic inflammatory response in many different clinical entities. This study aims to determine if the NLR predicts the tumor stage in colorectal cancer patients in the preoperative period. Materials and methods: A total of 206 patients diagnosed with colorectal cancer and admitted for surgical treatment over a 6-year period were identified from a retrospectively maintained database. NLR was calculated from preoperative full blood counts. NLRs were compared with the tumor stages as determined in histopathological reports and scanning tests to determine the extent of metastasis. Results: We found NLRs to be statistically higher in patients with T3 and T4 tumors than in patients with T1 and T2 tumors (mean: 5.261 vs. 4.499, respectively, P = 0.010). Similarly, we found statistically higher NLR values in the N1 and N2 groups than in the N0 group (mean: 6.597 vs. 4.501, respectively, P < 0.001). Additionally, NLRs were statistically higher in M1 patients than in M0 patients (mean: 8.261 vs. 5.158, respectively, P = 0.004). Conclusion: In the preoperative period, NLR was found to be a valuable predictive parameter for tumor staging in patients with colorectal cancer, thus informing us as to the kind of tumor we will meet when we open the abdomen.

Anahtar Kelimeler:

Key words: Systemic inflammatory response syndrome, colorectal neoplasms, neoplasm staging

Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer

Keywords:

Key words: Systemic inflammatory response syndrome, colorectal neoplasms, neoplasm staging,

PDF

___

Tilki SÜ, Engin H, Gökmen A, Bilir C, Üstündağ Y. Plasma soluble thrombomodulin and soluble endothelial protein C receptor levels in colorectal cancer patients. Turk J Med Sci 2013; 43: 194–198.
Sayan CD, Özakşit MG, Sarıkaya E, Eryılmaz ÖG, Mollamahmutoğlu L, Deveer R. Serum interleukin-8, CA- 125 levels, neutrophil-to-lymphocyte ratios, and combined markers in diagnosis of endometriosis. Turk J Med Sci 2013; 43: 417–423.
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 3: 181–184.
Mallappa S, Sinha A, Gupta S, Chadwick S. Preoperative neutrophil lymphocyte ratio greater than five is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 2013; 3: 323–328.
Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009; 3: 614–622.
Cook EJ, Steward RW, Farooq N, Alberts JC, Justin TA, Keeling NJ. Post-operative neutrophil–lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 2007; 1: 27–30.
Rashid F, Waraich N, Bhatti I, Saha S, Khan RN, Ahmed J, Leeder PC, Larvin M, Iftikhar SY. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol 2010; 8: 1.
Kim YH, Choi WJ. The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery. J Korean Surg Soc 2012; 6: 352–359.
Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD. Usefulness of the neutrophil to lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 2012; 1: 217–224.